Stem Cell Research and News: France
<-- Back To RegionsMEPs Challenge EU Stem Cell Research
In the context of the proposed new EU framework programme for research (FP7), a group of members of the Parliament (MEPs) are calling for the Community to stop the EU funding for human stem cell research. As some EU countries...
Posted in Today's Stem Cell Research on October 4, 2005 06:24 PM
Isolation of Adult Muscle Stem Cells for Skeletal Muscle Repair
EuroStemCell researchers from the Institut Pasteur have isolated muscle stem cells displaying a high potential for muscle repair. These stem cells are much more effective in promoting muscle repair than the cultured cells previously used. This work, published on September...
Posted in Today's Stem Cell Research on September 13, 2005 06:10 PM
France Approves Importation of Stem Cell Lines
France has approved, with certain restrictions, the importing of stem cell lines for stem cell research development. Nine ministerial orders were published in France's official journal on July 23, 2005 give a restricted licence to a number of national research...
Posted in Today's Stem Cell Research on August 1, 2005 05:38 PM
StemCyte, Inc. Completes Significant Round of Financing
Leader in Stem Cell Technology Adds New Investors ARCADIA, Calif., July 19 /PRNewswire/ - StemCyte®, Inc., a leading umbilical cord blood stem cell transplantation and therapeutic products company, today announced it has recently completed a significant round of financing from...
Posted in Today's Stem Cell Research on July 26, 2005 01:55 PM
Bioindustry Disappointed by Commission's Uncertain Position on Patenting
The European association for bioindustries, EuropaBio, has expressed its disappointment at the failure of the European Commission to take a position on the patenting of human DNA and human stem cells, which were not clarified in the EU Biotechnology Patents...
Posted in Today's Stem Cell Research on July 25, 2005 11:09 AM
MultiCell Technologies and XenoTech LLC Jointly Announce Shrink Wrap Vial Sales Launch for Immortalized Hepatocytes
New Procedure Expected to Speed Adoption Through Reduced Sales Cycle LINCOLN, R.I. – (BUSINESS WIRE) – June 15, 2005 – MultiCell Technologies, Inc. (OTCBB: MCET), a leading supplier of immortalized non-tumorgenic human hepatocytes as pharmaceutical candidate optimization tools, announced sales...
Posted in Today's Stem Cell Research on June 16, 2005 11:58 PM
MultiCell and XenoTech to Exhibit Immortalized Hepatocytes at New European Exhibition
LINCOLN, R.I.--(BUSINESS WIRE)--Jun 9, 2005 - MultiCell Technologies, Inc. (OTCBB: MCET) a leading supplier of immortalized human hepatic cell lines for pharmaceutical candidate optimization, announced today that it will attend the inaugural Pharmaceutical Sciences Fair and Exhibition in Nice, France,...
Posted in Today's Stem Cell Research on June 9, 2005 08:43 PM
Chemokine Therapeutics to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference
VANCOUVER, May 2 /PRNewswire-FirstCall/ - Chemokine Therapeutics Corp. (Toronto Stock Exchange: CTI), a biotechnology company developing drugs in the field of chemokines and cytokines, today announced that Dr. Hassan Salari, President and CEO, will be presenting at the Rodman and...
Posted in Today's Stem Cell Research on May 4, 2005 03:12 PM
The Costs Of Cord Blood Banking in India
It costs Rs 59,900 to store stem cells for 21 years. Cord blood stem cells, can now be banked like savings for a rainy day. A 16,000 sq ft lab at Keelakotaiyur near Chennai has just been set up to...
Posted in Today's Stem Cell Research on March 9, 2005 01:12 PM
Early Allogeneic Stem Cell Transplants Benefit Acute Myeloid Leukemia
French researchers are reporting that allogeneic stem cell transplants in first complete remission (CR) benefit intermediate- but not good- or poor-risk patients with acute myeloid leukemia (AML). The details of an analysis of 17 years of study were presented at...
Posted in Today's Stem Cell Research on February 23, 2005 03:28 AM